Researchers developed a new algorithm that can use a single OCT scan to predict whether a patient with diabetic macular edema is likely to respond to anti-VEGF treatments. They tested it on pretreatment OCT images (top row) and used post-treatment OCT images (bottom row) to track response to treatment. Case 24 and 36 responded to treatment.
Credit: Sina Farsiu, Duke University
New algorithm poised to help doctors individualize treatment for diabetic macular edema
A new approach that uses artificial intelligence to analyze retinal images could one day help doctors select the best treatment for patients with vision loss from diabetic macular edema. This diabetes complication is a major cause of vision loss among working-age adults.
Anti-vascular endothelial growth factor (VEGF) agents are widely used as the first line of therapy for diabetic macular edema, but they don’t work for everyone. There’s a need to identify who would benefit from the therapy because it requires multiple injections that are costly and burdensome for both patients and physicians.
“We developed an algorithm that can be used to automatically analyze optical coherence tomography (OCT) images of the retina to predict whether a patient is likely to respond to anti-VEGF treatments,” said research team leader Sina Farsiu from Duke University. “This research represents a step toward precision medicine, in which such predictions help clinicians better select first-line therapies for patients based on specific disease conditions.”
In The Optical Society (OSA) journal Biomedical Optics Express, Farsiu and colleagues show that the new algorithm can analyze just one pre-treatment volumetric scan to accurately predict whether a patient is likely to respond to anti-VEGF therapy.
“Our approach could potentially be used in eye clinics to prevent unnecessary and costly trial-and-error treatments and thus alleviate a substantial treatment burden for patients,” Farsiu said. “The algorithm could also be adapted to predict therapy response for many other eye diseases, including neovascular age-related macular degeneration.”
Predicting treatment response
The algorithm developed by the researchers is based on a novel convolutional neural network (CNN) architecture, a type of artificial intelligence that can analyze images by assigning importance to various aspects or objects. They used the algorithm to examine images acquired with OCT, a noninvasive technology that produces high-resolution cross-sectional retinal images and is the standard of care for assessing and treating many eye conditions.
“Unlike previously developed approaches, our algorithm requires OCT images from only a single pretreatment timepoint,” said Reza Rasti, first author of the paper and a postdoctoral scholar in Farsiu’s laboratory. “There’s no need for time-series OCT images, patient records or other metadata to predict therapy response.”
The new algorithm preserves and highlights global structures in the OCT image while enhancing local features from diseased regions to efficiently use retinal thickness information. To help with treatment decision making, the researchers incorporated an additional step that looks for CNN-encoded features that are highly correlated with anti-VEGF response.
Testing the algorithm
The researchers tested their new algorithm with OCT images from 127 patients who had been treated for diabetic macular edema with three consecutive injections of anti-VEGF agents. They applied the algorithm to analyze OCT images taken before the anti-VEGF injections, then compared the algorithm’s predictions to OCT images taken after anti-VEGF therapy to confirm whether the therapy improved the condition.
Based on the results, the researchers calculated that the algorithm would have an 87 percent chance of correctly predicting who would respond to treatment. It exhibited an average precision and specificity of 85 percent and a sensitivity of 80 percent.
Next, the researchers plan to confirm and extend the findings from this pilot study by performing a larger observational trial of patients who have not yet undergone treatment.
The Latest Updates from Bing News & Google News
Go deeper with Bing News on:
Diabetic macular edema
- Quantification of Diabetic Retinopathy Lesions in DME Patients With Intravitreal Conbercept Treatment Using Deep Learningon February 21, 2020 at 11:51 am
PATIENTS AND METHODS: Retrospective analyses were conducted of 3,496 color fundus photography images from 19 patients with clinically significant diabetic macular edema receiving conbercept treatment.
- Goals of Therapy When Treating Diabetic Retinopathyon February 21, 2020 at 10:37 am
Jose Martinez, MD, and Robert Wong, MD, review treatment plans for patients with mild, moderate, and more severe forms of diabetic retinopathy. Welcome the the new and improved AJMC.com, the premier ...
- OCS-01 shows clinical proof of concept in DME treatmenton February 20, 2020 at 8:40 am
Phase 2 data for OCS-01, a proprietary topical nanoparticle formulation of dexamethasone from Oculis to treat patients with diabetic macular edema, demonstrated clinical proof of concept as a topical ...
- Macular Edema and Macular Degeneration Market Share, Trends and Analysis, Growth and Forecast 2020 - 2026on February 20, 2020 at 7:19 am
Macular edema can be of two types, namely cystoid macular edema and diabetic macular edema. In addition to this, the macular degeneration is a condition in which the loss of vision occurs due to the ...
- Diabetic Macular Edema Pipeline Review - H1 2020 - ResearchAndMarkets.comon February 20, 2020 at 5:58 am
DUBLIN--(BUSINESS WIRE)--The "Diabetic Macular Edema - Pipeline Review, H1 2020" drug pipelines has been added to ResearchAndMarkets.com's offering. Summary The latest Pharmaceutical and Healthcare ...
Go deeper with Google Headlines on:
Diabetic macular edema
Go deeper with Bing News on:
Diabetes related vision loss
- 14 Possible Causes of Blurry Visionon February 20, 2020 at 8:43 am
Blurry vision is one of the most common eye symptoms. Learn what conditions—big and small—could be causing it.
- Isotope Tool to Help Fight Childhood Obesity Now in Use in Southern and Eastern Europeon February 19, 2020 at 5:44 am
With a long-term vision ... Health-Related Environmental Studies Section at the IAEA. “The deuterium dilution technique is the right technique to verify whether interventions to prevent or reduce ...
- Diabetic Retinopathy Treatment Market | Top Key Players, Revenue, Growth Factors, Trends, Analysis and Forecast till -2026on February 19, 2020 at 2:47 am
Diabetic Retinopathy Treatment Market by Top key Players are Regeneron Pharmaceuticals, Inc., Oxurion NV, Novartis AG, F. Hoffmann-La Roche Ltd., Pfizer Inc., Alimera Sciences, Bayer AG, Abbott ...
- Telford woman takes on 22-mile charity swimming challengeon February 13, 2020 at 10:09 pm
A year ago I was talking about needing bariatric surgery and worrying about diabetes-related complications ... two diabetes can lead to devastating complications, including sight loss, nerve damage, ...
- When Eyes & Ears Fail: Age-Related Hearing & Vision Loss In Dogson February 12, 2020 at 12:13 pm
... the dog has both acute vision loss and painful red eyes, it may be related to glaucoma, which requires emergency treatment. Cataracts: These white opacities in the lens of the eye block vision.